The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials-Reference-Cited by-同舟云学术

The efficacy, safety, and adverse events of azapirones in anxiety disorders: A systematic review and meta-analysis of randomized controlled trials

Published:2023-11 Issue: Volume:76 Page:23-51
ISSN:0924-977X
Container-title:European Neuropsychopharmacology
language:en
Short-container-title:European Neuropsychopharmacology

Author:

Rossano Flavia,Caiazza Claudio,Zotti Nicolas^ORCID,Viacava Luca,Irano Antonella,Solini Niccolò^ORCID,Pistone Luca^ORCID,Pezone Rosanna,Cilmi Flavia,Ricci Claudio,De Prisco Michele^ORCID,Iasevoli Felice,Kishi Taro,Solmi Marco,de Bartolomeis Andrea,Fornaro Michele^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biological Psychiatry,Psychiatry and Mental health,Neurology (clinical),Neurology,Pharmacology

Reference121 articles.

1. Administration, U.F.a.D., 2016. FDA requires strong warnings for opioid analgesics, prescription opioid cough products, and benzodiazepine labeling related to serious risks and death from combined use, in: Release, F.N. (Ed.).

2. Benzodiazepine Misuse in the Elderly: risk Factors, Consequences, and Management;Airagnes;Curr. Psych. Rep,2016

3. The serotonin-1A receptor in anxiety disorders;Akimova;Biol. Psych.,2009

4. Autonomic arousal in childhood anxiety disorders: associations with state anxiety and social anxiety disorder;Alkozei;J. Affect. Disord,2015

5. Controlled comparison of buspirone and oxazepam in generalized anxiety;Ansseau;Neuropsychobiology,1990

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insomnia and related mental health conditions: Essential neurobiological underpinnings towards reduced polypharmacy utilization rates;Sleep Medicine;2024-01